About the Editors


Tim Witney, PhD
King's College London
London, UK


Dr Witney's research focuses on the development of next-generation molecular imaging tools for cancer diagnosis, monitoring of therapeutic response, and detection of drug resistance. Specifically, his research group uses these tools to better-understand the role of antioxidant production and cellular metabolism in therapy-resistant tumours. Through these specific vulnerabilities, he is creating a new class of precision radionuclide therapies that target and treat drug-resistant cancer.

Associate Editors

Erik Aarntzen, MD, PhD
Department of Medical Imaging, Radboud University Medical Center
Nijmegen, The Netherlands


Dr Aarntzen's research activities are focused on developing molecular imaging, in particular PET imaging, as a biomarker technology in immunology-oriented research and clinical practice.

Federica Pisaneschi, PhD
Center for Translational Cancer Research, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (IMM), University of Texas Health Science Center at Houston
Houston, TX, USA

Dr Pisaneschi is a radiochemist, radiopharmaceuticals developer and molecular imaginer. Her research is focused on the development of new radiopharmaceuticals for cancer treatment and the use of imaging to guide personalized therapy. She has contributed to the field with several peer reviewed publications, patents and presentations to national and international conferences. She is member in professional societies in the field and active especially in regard of educational activities. Her current focus is on PET imaging of neuroinflammation, multimodal metabolic imaging of prostate cancer, and targeted radiotherapy.

John A Ronald, PhD
Department of Medical Biophysics, Robarts Research Institute, The University of Western Ontario
London, Ontario, Canada

Dr Ronald's research focuses on the development of molecular imaging technologies for early cancer detection and treatment monitoring. General areas of interest are building tools to monitor cell-based immunotherapies, gene-based cancer theranostics, and application of imaging to genome editing technologies.

Adam Shuhendler, PhD
Department of Chemistry & Biomolecular Sciences, University of Ottawa
Ottawa, Ontario, Canada

Dr Shuhendler's research interest surrounds what molecular imaging can do to result in better diagnoses and therapy tailored to the individual patient. Across modalities, including MRI, PET, and OCT, my research group generates new imaging probes comprised of small molecules, nanoparticles, and polymers to bring new functionality to diagnostic imaging. With an eye on activity-based sensing, we are tackling the diagnosis of kidney disease, concussion, and cardiovascular disease, as well as the prognosis of cancer.

Lingyan Shi, PhD
University of California, San Diego
La Jolla, CA, USA

Prof Lingyan Shi's research interest focuses on developing super-resolution optical spectroscopy and multiplex chemical imaging platforms (such as A-POD, and PRM-SRS), and the applications for studying metabolic dynamics in aging and diseases. She discovered “Golden Window” for deep tissue imaging, and developed deuterium-probed metabolic imaging platform that combines deuterium-probing and stimulated Raman scattering (DO-SRS and STRIDE) for visualizing metabolic activities in situ.

Weisong Zhao, PhD
Harbin Institute of Technology
Harbin, China

Professor and PI at Harbin Institute of Technology (HIT). His research focuses on advanced microscopy, machine learning, and bioimage analysis. His lab is building advanced optical microscopy for biomedical applications, as well as developing smart algorithms across modalities including optical microscopy, acoustic/photoacoustic imaging, and cryo-EM/ET.

Iris Yuwen Zhou, PhD
Massachusetts General Hospital and Harvard Medical School
Boston, MA, USA

Dr Zhou's work focuses on developing novel MRI methodologies that quantify molecular, metabolic, functional, and structural alterations for stroke, fibrosis, and tumor imaging. Her research spans tissue characterization using molecularly targeted probes, chemical exchange saturation transfer (CEST), diffusion, functional MRI in animal models, and clinical translation. Her current research topics also include the integration of multi-parametric MRI data with information from other imaging modalities, such as positron emission tomography (PET), through leveraging advances in multi-modal imaging, chemistry, signal modeling, and image analysis.

Advisory Editors

Rita Strack, PhD

Rita Strack obtained her Ph.D. in Biochemistry and Molecular Biology from the University of Chicago. While there, she worked with Benjamin Glick and Robert Keenan to engineer improved variants of the red fluorescent protein DsRed, and also studied the chemical mechanism of chromophore formation in DsRed. She continued her research as a postdoctoral fellow in Samie Jaffrey's laboratory at Weill Cornell Medical College, where she developed fluorescent reporters for live-cell imaging of RNA such as Spinach2. She joined Nature Methods in 2014 and handles imaging, microscopy and probes, along with protein and RNA biochemistry content for the journal.

Nelio Rodrigues, PhD

Nelio joined the Biotechnology team at Nature Communications in July 2022. Following his undergraduate studies at the University of Coimbra and Utrecht University, he undertook his PhD research at University College London, focusing on tissue mechanics and cell shape changes in mitosis. He then continued his research at the Francis Crick Institute in London, where he investigated the molecular and biophysical principles that underlie cell polarity and asymmetric cell division. At Nature Communications, he handles manuscripts in the areas of cell biology, biotechnology, microscopy, and imaging technologies.

Editorial Board Members

Frauke Alves, MD
Translational Molecular Imaging, University Medical Center Göttingen and Max-Planck for Multidisciplinary Sciences
Göttingen, Germany

Steve J Archibald, PhD
King's College London
London, UK

Zaver M Bhujwalla, PhD
Russell H Morgan Department of Radiology, Johns Hopkins University School of Medicine
Baltimore, MD, USA

Leo M Carlin, PhD
Cancer Research UK Scotland Institute
Glasgow, UK

Ann-Marie Chacko, PhD
Duke-NUS Medical School

Kevin C Chan, PhD
New York University Grossman School of Medicine
New York, NY, USA

Freddy E Escorcia, MD, PhD
National Cancer Institute
Bethesda, MD, USA

Ling Fu, PhD
School of Physics and Optoelectronic Engineering, Hainan University
Haikou, China

Gilbert O Fruhwirth, PhD
King's College London / Cancer and Pharmaceutical Sciences
London, UK

Jason P. Holland, DPhil

University of Zurich
Zurich, Switzerland

Oluwatayo F Ikotun, PhD
University of California, Los Angeles
Los Angeles, California, USA

Michelle L. James, PhD
Stanford University
California, USA

Fabian Kiessling, MD
Institute for Experimental Molecular Imaging, RWTH Aachen University
Aachen, Germany

Twan Lammers, PhD, DSc
RWTH Aachen University Clinic
Aachen, Germany

Mandy van Leent, PhD
Icahn School of Medicine at Mount Sinai
New York, NY, USA

David Yestin Lewis, MD, PhD
Cancer Research UK Beatson Institute and University of Glasgow
Glasgow, Scotland, UK

Jason S Lewis, PhD
Memorial Sloan Kettering Cancer Center
New York, NY, USA

Aaron M Mohs, PhD
University of Nebraska Medical Center
Omaha, NE, USA

Bartlomiej W Papiez, PhD
Big Data Institute, University of Oxford
Oxford, UK

Vladimir Ponomarev, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY, USA

Rajendra Prasad, PhD
Indian Institute of Technology (BHU)
Varanasi, India

Peter J. H. Scott, PhD
University of Michigan
Ann Arbor MI, USA

Gaurav Sharma, PhD
UT Southwestern Medical Center
Dallas, TX

Noam Shemesh, PhD
Champalimaud Foundation
Lisbon, Portugal

Xiaoyu Shi, PhD
University of California, Irvine
Irvine, CA, USA

Jonathan D Thiessen, PhD
Lawson Health Research Institute
London, ON, Canada

Mei Tian, MD, PhD
Executive President, Human Phenome Institute, Fudan University
Shanghai, China

Raju Tomer, PhD
Department of Biological Sciences, Columbia University
New York, NY, USA

Syed Muhammad Usama, PhD
University of Texas at San Antonio
San Antonio, Texas, USA

Claire L Walsh, PhD
Department of Mechanical Engineering, University College London
London, UK

Guang Yang, PhD
Imperial College London
London, UK

Giannis Zacharakis, PhD
Heraklion, Crete, Greece

Kirstin A Zettlitz, PhD
Beckman Research Institute, City of Hope
Duarte, CA, USA

Jing Yuan, PhD
Huazhong University of Science and Technology
Wuhan, China


Interested in joining the journal team?

If you are interested in joining the journal as an Editorial Board Member or Associate Editor, please complete this Google form. Associate Editors are part of the editorial team that handle manuscripts, while Editorial Board Members are regular reviewers and are consulted for ad hoc advice. We will contact you if your expertise meets the needs of the journal.

Nature Portfolio journals are committed to promoting practices that support diversity, equity and inclusion in science communication and publishing, and we strongly encourage gender, race, ethnic, geographic, career stage and other diversity in our journal teams. Our in-house staff will use your information only for the purposes of identifying new editorial team or board members. Please contact the journal by email if you would like to remove your information from these records.

Please note that we are not able to respond to all applicants.